NASPGHAN Foundation Mission
The NASPGHAN Foundation funds and supports the research and education missions of NASPGHAN in order to enhance the health and well-being of children with gastrointestinal, liver, pancreas and nutritional disorders.
Supporting the NASPGHAN Foundation's Mission
The NASPGHAN Foundation is pleased to recognize and thank our industry and organizational supporters. They help us fulfill our mission to further the well-being of children with digestive diseases.
- Abbott
- AbbVie, Inc.
- Albireo Pharma, Inc.
- Alcresta Therapeutics, Inc.
- Allakos, Inc.
- American Partnership for Eosinophilic Disorders (APFED)
- AstraZeneca
- Avanos Medical
- Boston Children’s Hospital
- Children’s Hospital of Philadelphia
- Crohn’s & Colitis Foundation
- Cyclic Vomiting Syndrome Association
- Evo Endo
- Evolve Biosystems
- Feeding Matters
- Fresenius Kabi
- Gerber Products Company
- Gilead Sciences, Inc.
- Innovative Health Solutions, Inc.
- Joli Diagnostic
- Laborie Medical Technologies Corp.
- Lilly
- Medtronic
- Mirum Pharmaceuticals, Inc.
- Nestlé
- Nutricia North America
- Olympus America, Inc.
- Parapharma Tech
- Pfizer, Inc.
- QOL Medical, LLC
- Reckitt/Mead Johnson Nutrition
- Regeneron Pharmaceuticals
- Takeda Pharmaceuticals, Inc.
- Travere Therapeutics
